The Latest Advances in Systemic Mastocystosis Molecular Biology Could Change Future Treatment
source: pixabay.com

The Latest Advances in Systemic Mastocystosis Molecular Biology Could Change Future Treatment

By Lauren Thayer from In The Cloud Copy Systemic mastocytosis (SM) is a complicated condition of the blood in which excessive numbers of mast cells (a type of white blood…

Continue Reading The Latest Advances in Systemic Mastocystosis Molecular Biology Could Change Future Treatment
Study: Avapritinib Shows No Adverse Effects in Phase II Trial for Systematic Mastocytosis
source: pixabay.com

Study: Avapritinib Shows No Adverse Effects in Phase II Trial for Systematic Mastocytosis

  A PIONEER trial has been conducted in order to evaluate the effects of avapritinib, a drug meant to treat systematic mastocytosis. Researchers want to find a better treatment for…

Continue Reading Study: Avapritinib Shows No Adverse Effects in Phase II Trial for Systematic Mastocytosis
Experimental Systemic Mastocytosis Treatment Displays Potential in Early Trials
qimono / Pixabay

Experimental Systemic Mastocytosis Treatment Displays Potential in Early Trials

According to a story from PR Newswire, the Blueprint Medicines Corporation recently announced that latest results from a Phase 1 clinical trial of avapritinib as a treatment for advanced systemic…

Continue Reading Experimental Systemic Mastocytosis Treatment Displays Potential in Early Trials
Data From a Phase I Study of a Drug to Treat Systemic Mastocytosis Has Been Released
jarmoluk / Pixabay

Data From a Phase I Study of a Drug to Treat Systemic Mastocytosis Has Been Released

Promising data from the ongoing Phase I clinical trial Explorer has been announced by Blueprint Medicines Corporation. The trial is designed to evaluate the effects of the experimental drug avapritinib…

Continue Reading Data From a Phase I Study of a Drug to Treat Systemic Mastocytosis Has Been Released
Close Menu